BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15355975)

  • 1. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.
    Okahara F; Ikawa H; Kanaho Y; Maehama T
    J Biol Chem; 2004 Oct; 279(44):45300-3. PubMed ID: 15355975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
    Maehama T; Okahara F; Kanaho Y
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions.
    Torres J; Rodriguez J; Myers MP; Valiente M; Graves JD; Tonks NK; Pulido R
    J Biol Chem; 2003 Aug; 278(33):30652-60. PubMed ID: 12788938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.
    Georgescu MM; Kirsch KH; Akagi T; Shishido T; Hanafusa H
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10182-7. PubMed ID: 10468583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the PTEN phosphatase.
    Gericke A; Munson M; Ross AH
    Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
    Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
    Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.
    Valiente M; Andrés-Pons A; Gomar B; Torres J; Gil A; Tapparel C; Antonarakis SE; Pulido R
    J Biol Chem; 2005 Aug; 280(32):28936-43. PubMed ID: 15951562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
    Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
    J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.
    Okahara F; Itoh K; Nakagawara A; Murakami M; Kanaho Y; Maehama T
    Mol Biol Cell; 2006 Nov; 17(11):4888-95. PubMed ID: 16971513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.
    Torres J; Pulido R
    J Biol Chem; 2001 Jan; 276(2):993-8. PubMed ID: 11035045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus.
    Chen H; Mei L; Zhou L; Zhang X; Guo C; Li J; Wang H; Zhu Y; Zheng Y; Huang L
    Int J Biochem Cell Biol; 2011 Apr; 43(4):545-55. PubMed ID: 21167305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct identification of PTEN phosphorylation sites.
    Miller SJ; Lou DY; Seldin DC; Lane WS; Neel BG
    FEBS Lett; 2002 Sep; 528(1-3):145-53. PubMed ID: 12297295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
    Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
    Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells.
    Wu W; Wang X; Zhang W; Reed W; Samet JM; Whang YE; Ghio AJ
    J Biol Chem; 2003 Jul; 278(30):28258-63. PubMed ID: 12743124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
    Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
    Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation.
    Birle D; Bottini N; Williams S; Huynh H; deBelle I; Adamson E; Mustelin T
    J Immunol; 2002 Jul; 169(1):286-91. PubMed ID: 12077256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-binding and activation mechanism of PTEN.
    Das S; Dixon JE; Cho W
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7491-6. PubMed ID: 12808147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.